DE60325107D1 - Verfahren und kit zum quantitativen und/oder qualitativen nachweis von komponenten in einer probe - Google Patents

Verfahren und kit zum quantitativen und/oder qualitativen nachweis von komponenten in einer probe

Info

Publication number
DE60325107D1
DE60325107D1 DE60325107T DE60325107T DE60325107D1 DE 60325107 D1 DE60325107 D1 DE 60325107D1 DE 60325107 T DE60325107 T DE 60325107T DE 60325107 T DE60325107 T DE 60325107T DE 60325107 D1 DE60325107 D1 DE 60325107D1
Authority
DE
Germany
Prior art keywords
components
kit
quantitative
sample
qualitative detection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60325107T
Other languages
English (en)
Inventor
Marc Ramael
Jean-Paul Sanders
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE60325107D1 publication Critical patent/DE60325107D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/969—Multiple layering of reactants
DE60325107T 2003-08-25 2003-08-25 Verfahren und kit zum quantitativen und/oder qualitativen nachweis von komponenten in einer probe Expired - Lifetime DE60325107D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2003/009393 WO2005019820A1 (en) 2003-08-25 2003-08-25 A method and kit for the quantitative and/or qualitative detection of components in a sample

Publications (1)

Publication Number Publication Date
DE60325107D1 true DE60325107D1 (de) 2009-01-15

Family

ID=34203140

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60325107T Expired - Lifetime DE60325107D1 (de) 2003-08-25 2003-08-25 Verfahren und kit zum quantitativen und/oder qualitativen nachweis von komponenten in einer probe

Country Status (6)

Country Link
US (1) US7510881B2 (de)
EP (1) EP1658497B1 (de)
AT (1) ATE416384T1 (de)
AU (1) AU2003260457A1 (de)
DE (1) DE60325107D1 (de)
WO (1) WO2005019820A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9487575B2 (en) 2004-07-14 2016-11-08 The Regents Of The University Of California Compositions and methods for treatment of gynecologic cancers
EP2848942B1 (de) * 2004-07-14 2017-03-08 The Regents of The University of California Biomarker zur Früherkennung von Eierstockkrebs
US9488655B2 (en) * 2004-07-14 2016-11-08 The Regents Of The University Of California Biomarkers for detection of early- and late-stage endometrial cancer
CA2672961A1 (en) * 2006-12-19 2008-07-10 Danute Bankaitis-Davis Gene expression profiling for identification, monitoring, and treatment of ocular disease
WO2010007528A2 (en) * 2008-07-17 2010-01-21 Andreas Pfuetzner Biomarkers for insulin efficacy
DE102009010563A1 (de) 2009-02-16 2010-08-26 Matthias W. Engel Vorrichtung zum Nachweis von Analyten in Körperflüssigkeiten
DE102009021734B4 (de) * 2009-05-12 2012-02-02 Eberhard-Karls-Universität Tübingen Universitätsklinikum Diagnostische Marker für die Bestimmung der Prädisposition der Entwicklung von Gebärmutterhalskrebs und für die Bestimmung eingesetzte Oligonukleotide
US8486717B2 (en) 2011-01-18 2013-07-16 Symbolics, Llc Lateral flow assays using two dimensional features
EP2594334A1 (de) 2011-11-21 2013-05-22 Drive O2 Probenfläschchen zur digitalen holographischen Analyse einer flüssigen Zellprobe
US9241976B2 (en) 2011-08-29 2016-01-26 The Regents Of The University Of California Use of HDL-related molecules to treat and prevent proinflammatory conditions
US9874556B2 (en) 2012-07-18 2018-01-23 Symbolics, Llc Lateral flow assays using two dimensional features
US9599615B2 (en) 2013-03-13 2017-03-21 Symbolics, Llc Lateral flow assays using two dimensional test and control signal readout patterns
SE538541C2 (en) 2015-01-19 2016-09-13 Fogelstrand Per Method for preparing a biological sample for use in an immunolabeling process
US11340218B2 (en) 2016-05-25 2022-05-24 Kromnigon Ab Method for preparing a biological sample for use in an immunolabeling process
WO2019197365A1 (en) * 2018-04-09 2019-10-17 Expedeon Ltd. Chemical and biological complexes and conjugates with multiple labels and applications thereof
CN111474360B (zh) * 2020-05-18 2023-10-10 四川新健康成生物股份有限公司 一种干式荧光免疫检测仪
CN114167064A (zh) * 2021-12-02 2022-03-11 安徽大千生物工程有限公司 一种sdf-1测定试剂盒及其制备与检测方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8501219A (nl) * 1985-04-29 1986-11-17 Stichting Vrienden Van De Stic Immunologisch complex, de bereiding en toepassing daarvan.
US5223242A (en) * 1985-11-05 1993-06-29 The General Hospital Corporation Negatively charged specific affinity reagents
US5196306A (en) * 1989-03-29 1993-03-23 E. I. Du Pont De Nemours And Company Method for the detection or quantitation of an analyte using an analyte dependent enzyme activation system
US5296347A (en) * 1991-02-08 1994-03-22 Ciba Corning Diagnostics Corp. Bridge immunoassay
US20030008410A1 (en) * 1995-03-13 2003-01-09 Hechinger Mark K. Immunoassay apparatus, kit and methods
US6117631A (en) * 1996-10-29 2000-09-12 Polyprobe, Inc. Detection of antigens via oligonucleotide antibody conjugates
WO1998038513A1 (en) * 1997-02-26 1998-09-03 Khaw Ban An Signal enhancement of bispecific antibody-polymer probe for immunoassay use

Also Published As

Publication number Publication date
US20060286546A1 (en) 2006-12-21
AU2003260457A1 (en) 2005-03-10
WO2005019820A1 (en) 2005-03-03
ATE416384T1 (de) 2008-12-15
EP1658497A1 (de) 2006-05-24
EP1658497B1 (de) 2008-12-03
US7510881B2 (en) 2009-03-31

Similar Documents

Publication Publication Date Title
DE60325107D1 (de) Verfahren und kit zum quantitativen und/oder qualitativen nachweis von komponenten in einer probe
ATE425266T1 (de) Aptamer-nanopartikelkonjugate und verwendungsverfahren zur detektion von zielanalyten
DE69904956T2 (de) Testsatz und verfahren zur qualitätsprüfung von einem iontophoretischen probenahmesystem
DK2082226T3 (da) Sekventiel analyse af biologiske prøver
ATE423972T1 (de) Vorrichtung und verfahren um gleichzeitig verschiedene antikörper und antigene nachzuweisen in klinischen, nahrungsmittel- und umwelt-proben
ATE402269T1 (de) Methoden und testsätze für annäherungstest
ATE418729T1 (de) Verfahren zur charakterisierung von biomolekülen mittels resultat-gesteuerter strategie
MX2007014815A (es) Metodos de inmunoanalisis mejorados.
BRPI0610092B8 (pt) métodos para a detecção de um analito e de um ácido nucleico em uma amostra, e de sintetização de uma molécula de ácido nucleico ou de análogo de ácido nucleico, kit reagente, uso do mesmo, molécula de ácido nucleico ou de análogo de ácido nucleico e produto associado
DE602005013957D1 (de) Verfahren zur durchführung von vollbluttests
DK2082239T3 (da) Sekventiel analyse af biologiske prøver med intermediær blegning af fluorescerensdetektor
DK1639130T3 (da) Prober, biblioteker og kits til analyse af blandinger af nukleinsyrer og metoder til opbygning af disse
ATE408829T1 (de) Verfahren und assaykits zum nachweis mononuklearer zellphänotypen
ATE529533T1 (de) Verfahren zum nachweis von analyten in einer probe
ATE478337T1 (de) Methoden zum nachweis analyten in proben
ATE330225T1 (de) Verfahren und testkit zum nachweis von analyten in einer probe
ATE408832T1 (de) Verfahren zum nachweis von blutzell-antigenen und gegen diese gerichtete antikörper
WO2002077645A3 (en) Method for the measurement of soluble analytes
DE50113987D1 (de) Verfahren zum Nachweis biologischer Moleküle
ATE534907T1 (de) Verfahren für den nachweis von l523s-expression in biologischen proben
ATE295537T1 (de) Testverfahren zum nachweiss von lipoproteinen
ATE295962T1 (de) Verfahren zum nachweis von analyten in proben mittels analysenelementen
ATE377191T1 (de) Verfahren zur analyse von stuhlproben für diagnostische zwecke
DE59910326D1 (de) Verwendung derivatisierter Reagenzien in Chemilumineszenz- und Elektrochemilumineszenz-Nachweisverfahren
NO20016080L (no) Analyse

Legal Events

Date Code Title Description
8364 No opposition during term of opposition